ROPIVACAINE ANHYDROUS: 13 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
13
Total FAERS Reports
0
Deaths Reported
11
Hospitalizations
13
As Primary/Secondary Suspect
2
Life-Threatening
Active Ingredient: ROPIVACAINE HYDROCHLORIDE ANHYDROUS ·
First Report: 20210311 · Latest Report: 20250522
What Are the Most Common ROPIVACAINE ANHYDROUS Side Effects?
#1 Most Reported
Motor dysfunction
5 reports (38.5%)
#2 Most Reported
Acute generalised exanthematous pustulosis
2 reports (15.4%)
#3 Most Reported
Tonic clonic movements
1 reports (7.7%)
All ROPIVACAINE ANHYDROUS Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Motor dysfunction | 5 | 38.5% | 0 | 5 |
Who Reports ROPIVACAINE ANHYDROUS Side Effects? Age & Gender Data
Gender: 84.6% female, 15.4% male. Average age: 39.8 years. Most reports from: FR. View detailed demographics →
Is ROPIVACAINE ANHYDROUS Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2021 | 1 | 0 | 1 |
| 2022 | 4 | 0 | 4 |
| 2023 | 3 | 0 | 1 |
| 2024 | 1 | 0 | 1 |
| 2025 | 4 | 0 | 4 |
What Is ROPIVACAINE ANHYDROUS Used For?
| Indication | Reports |
|---|---|
| Anaesthesia | 10 |
Official FDA Label for ROPIVACAINE ANHYDROUS
Official prescribing information from the FDA-approved drug label.